Shockwave Medical Company Insiders
SWAV Stock | USD 328.60 0.40 0.12% |
Shockwave Medical's insiders are aggressively selling. The analysis of insiders' sentiment of trading Shockwave Medical stock suggests that vertually all insiders are panicking at this time. Shockwave Medical employs about 1.5 K people. The company is managed by 22 executives with a total tenure of roughly 37 years, averaging almost 1.0 years of service per executive, having 66.73 employees per reported executive.
Shockwave Medical's Insider Buying Vs Selling
0
Selling | Buying |
Latest Trades
2024-03-26 | Laura Francis | Disposed 1500 @ 300 | View | ||
2024-03-06 | Trinh Phung | Disposed 21 @ 253.14 | View | ||
2024-02-26 | Isaac Zacharias | Disposed 4000 @ 260.36 | View | ||
2024-02-22 | Trinh Phung | Disposed 599 @ 259.24 | View | ||
2024-02-21 | Frederic H Moll | Disposed 60000 @ 257.39 | View | ||
2024-02-16 | Laura Francis | Disposed 1000 @ 250 | View | ||
2024-02-15 | Douglas Evan Godshall | Disposed 10000 @ 231.56 | View | ||
2024-02-06 | Frank T Watkins | Disposed 2000 @ 231.76 | View | ||
2024-02-01 | Dan Puckett | Disposed 3406 @ 229.76 | View | ||
2024-01-26 | Isaac Zacharias | Disposed 4000 @ 224.69 | View | ||
2024-01-16 | Douglas Evan Godshall | Disposed 10000 @ 217.59 | View | ||
2024-01-08 | Frank T Watkins | Disposed 2000 @ 198.99 | View | ||
2024-01-05 | Douglas Evan Godshall | Disposed 10000 @ 200.05 | View | ||
2023-12-26 | Isaac Zacharias | Disposed 4000 @ 192.5 | View | ||
2023-12-15 | Douglas Evan Godshall | Disposed 5000 @ 187.8 | View | ||
2023-12-08 | Dan Puckett | Disposed 200 @ 173.88 | View | ||
2023-12-07 | Trinh Phung | Disposed 203 @ 171.63 | View |
Monitoring Shockwave Medical's insider sentiment can offer insights into its future performance, as insiders often have access to more information about their company's operations, financial health, and upcoming initiatives than the general public. However, it's essential to note that insider trading is regulated by securities laws, and insiders are required to disclose their trades publicly to ensure transparency and prevent unfair advantages based on non-public information.
Shockwave |
Shockwave Medical's Workforce Through the Years
Please note that employee historical analysis has become an increasingly important factor for investors assessing the risk associated with Shockwave Medical's future performance. Based on our forecasts, it is anticipated that Shockwave will maintain a workforce of slightly above 1470 employees by May 2024.Shockwave Medical's latest congressional trading
Congressional trading in companies like Shockwave Medical, is subject to rigorous scrutiny to prevent conflicts of interest and insider trading. This is governed by multiple SEC regulations which were established to foster transparency and deter members of Congress from leveraging non-public information for personal gain. This oversight helps maintain public trust and ensures that investments in Shockwave Medical by those in governmental positions are based on the same information available to the general public.
2023-01-31 | Representative Daniel Goldman | Disposed Under $15K | Verify |
Shockwave Medical Management Team Effectiveness
The company has return on total asset (ROA) of 0.0938 % which means that it generated a profit of $0.0938 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.2496 %, meaning that it created $0.2496 on every $100 dollars invested by stockholders. Shockwave Medical's management efficiency ratios could be used to measure how well Shockwave Medical manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to climb to 0.11 in 2024. Return On Capital Employed is likely to climb to 0.12 in 2024. At this time, Shockwave Medical's Fixed Asset Turnover is fairly stable compared to the past year. Return On Assets is likely to climb to 0.1 in 2024, whereas Intangibles To Total Assets are likely to drop 0.07 in 2024.Net Income Applicable To Common Shares is likely to climb to about 260.8 M in 2024, whereas Common Stock Shares Outstanding is likely to drop slightly above 33.7 M in 2024.
Shockwave Medical Workforce Comparison
Shockwave Medical is rated second in number of employees category among related companies. The total workforce of Health Care industry is at this time estimated at about 8,358. Shockwave Medical retains roughly 1,468 in number of employees claiming about 18% of equities under Health Care industry.
The company has Profit Margin (PM) of 0.2 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.22 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.22. Shockwave Medical Insider Trading History
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Shockwave Medical insiders, such as employees or executives, is commonly permitted as long as it does not rely on Shockwave Medical's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, Shockwave Medical insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Buy/Sell Ratio | # Purchases Trades | # Sales Trades | Total Shares Purchased | Total Shares Sold | |
---|---|---|---|---|---|
2024-03-01 | 0.2593 | 21 | 81 | 235,001 | 313,391 |
2023-12-01 | 0.2045 | 9 | 44 | 34,143 | 74,252 |
2023-09-01 | 0.1778 | 8 | 45 | 51,610 | 116,640 |
2023-06-01 | 0.4375 | 14 | 32 | 16,605 | 41,191 |
2023-03-01 | 0.2222 | 12 | 54 | 89,862 | 162,282 |
2022-12-01 | 0.2286 | 8 | 35 | 45,300 | 101,158 |
2022-09-01 | 0.2121 | 7 | 33 | 40,550 | 85,836 |
2022-06-01 | 0.3404 | 16 | 47 | 36,100 | 89,064 |
2022-03-01 | 0.2373 | 14 | 59 | 96,957 | 121,403 |
2021-12-01 | 0.0816 | 8 | 98 | 96,454 | 189,154 |
2021-09-01 | 0.1143 | 12 | 105 | 60,500 | 137,000 |
2021-06-01 | 0.2061 | 27 | 131 | 98,813 | 307,313 |
2021-03-01 | 0.1648 | 15 | 91 | 146,362 | 1,055,684 |
2020-12-01 | 0.2169 | 18 | 83 | 318,000 | 1,028,955 |
2020-09-01 | 0.3176 | 27 | 85 | 232,104 | 2,134,927 |
2020-06-01 | 0.1212 | 4 | 33 | 42,000 | 686,966 |
2020-03-01 | 0.1951 | 8 | 41 | 236,200 | 1,184,000 |
2019-12-01 | 0.3333 | 5 | 15 | 42,000 | 99,000 |
2019-09-01 | 0.375 | 3 | 8 | 75,000 | 1,450,000 |
2019-03-01 | 1.52 | 38 | 25 | 21,476,820 | 8,173,637 |
Shockwave Medical Notable Stakeholders
A Shockwave Medical stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Shockwave Medical often face trade-offs trying to please all of them. Shockwave Medical's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Shockwave Medical's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
John Adams | CoFounder Advisor | Profile | |
Daniel Hawkins | Founder Advisor | Profile | |
Douglas MBA | CEO President | Profile | |
Dan Puckett | CFO | Profile | |
Antoine Papiernik | Director | Profile | |
Frederic Moll | Independent Director | Profile | |
Todd Brinton | Co-Founder, Director | Profile | |
Isaac Zacharias | Chief Officer | Profile | |
Debbie Kaster | Vice Relations | Profile | |
FACC FRCP | Chief Officer | Profile | |
Rob Williamson | VP Sales | Profile | |
Cathy Harnett | Senior Resources | Profile | |
Hajime JD | General Secretary | Profile | |
Patrick Stephens | Senior Development | Profile | |
Renee Gaeta | Chief Officer | Profile | |
Keith Dawkins | Chief Medical Officer | Profile | |
Daniel MBA | Principal CFO | Profile | |
Mike Maszy | VP Operations | Profile | |
Trinh Phung | Principal Officer | Profile | |
Robert Fletcher | Senior Access | Profile | |
Luis Morales | Senior Operations | Profile | |
Dave Cox | Vice Sales | Profile |
About Shockwave Medical Management Performance
The success or failure of an entity such as Shockwave Medical often depends on how effective the management is. Shockwave Medical management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Shockwave management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Shockwave management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Last Reported | Projected for Next Year | ||
Return On Tangible Assets | 0.10 | 0.11 | |
Return On Capital Employed | 0.11 | 0.12 | |
Return On Assets | 0.09 | 0.1 | |
Return On Equity | 0.22 | 0.23 |
The data published in Shockwave Medical's official financial statements usually reflect Shockwave Medical's business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of Shockwave Medical. For example, before you start analyzing numbers published by Shockwave accountants, it's critical to develop an understanding of what Shockwave Medical's liquidity, profitability, and earnings quality are in the context of the Health Care Equipment & Supplies space in which it operates.
Please note, the presentation of Shockwave Medical's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Shockwave Medical's management is honest, while the outside auditors are strict and uncompromising. Whatever the case, the imprecision that can be found in Shockwave Medical's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Shockwave Medical. Please utilize our Beneish M Score to check the likelihood of Shockwave Medical's management manipulating its earnings.
Shockwave Medical Workforce Analysis
Traditionally, organizations such as Shockwave Medical use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Shockwave Medical within its industry.Shockwave Medical Manpower Efficiency
Return on Shockwave Medical Manpower
Revenue Per Employee | 497.4K | |
Revenue Per Executive | 33.2M | |
Net Income Per Employee | 100.3K | |
Net Income Per Executive | 6.7M | |
Working Capital Per Employee | 763.7K | |
Working Capital Per Executive | 51M |
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Shockwave Medical. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in nation. For more information on how to buy Shockwave Stock please use our How to Invest in Shockwave Medical guide.Note that the Shockwave Medical information on this page should be used as a complementary analysis to other Shockwave Medical's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .
Complementary Tools for Shockwave Stock analysis
When running Shockwave Medical's price analysis, check to measure Shockwave Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Shockwave Medical is operating at the current time. Most of Shockwave Medical's value examination focuses on studying past and present price action to predict the probability of Shockwave Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Shockwave Medical's price. Additionally, you may evaluate how the addition of Shockwave Medical to your portfolios can decrease your overall portfolio volatility.
Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon |
Is Shockwave Medical's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Shockwave Medical. If investors know Shockwave will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Shockwave Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.69) | Earnings Share 3.85 | Revenue Per Share 19.894 | Quarterly Revenue Growth 0.409 | Return On Assets 0.0938 |
The market value of Shockwave Medical is measured differently than its book value, which is the value of Shockwave that is recorded on the company's balance sheet. Investors also form their own opinion of Shockwave Medical's value that differs from its market value or its book value, called intrinsic value, which is Shockwave Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Shockwave Medical's market value can be influenced by many factors that don't directly affect Shockwave Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Shockwave Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Shockwave Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Shockwave Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.